Zymtronix
Americas
Durham
,
United States
Scaleup
FOUNDED
2013
HEADCOUNT
2-20
FUNDING
Seed
Keywords:
cell_free, biocatalysis, enzymes, crop_protection, prebiotics
BUSINESS
Zymtronix develops a universal enzyme immobilization platform using magnetic nanoparticle scaffolds that self-assemble around enzymes, stabilizing them for industrial biocatalysis without loss of activity. The company has evolved from a pure immobilization technology provider into a cell-free biomanufacturing platform, using immobilized multi-enzyme cascades to produce ingredients for agriculture (herbicides, fungicides), nutrition (human milk bioactives), cosmetics, and pharmaceuticals. Partnerships include Tate and Lyle (food ingredient manufacturing), Ginkgo Bioworks (enzyme discovery and engineering), and Codexis (early partnership for pharmaceutical enzymes). The company relocated from Ithaca to Durham, North Carolina. Also developed ZymTox, a metabolic safety testing assay using immobilized human metabolic enzymes
BIOTECH INVOLVEMENT
Core; cell-free biocatalysis platform for sustainable ag and nutrition products.
TECHNOLOGY PLATFORM
cell-free enzyme systems; reusable carriers; biocatalysis
PRIMARY PRODUCTS
BioEnhanced herbicides; Biofungicides; HMOs (e.g., DSLNT)